Publikationer – Gustav Ullenhag

Publikationer i DiVA

Publikationer i PubMed

Ett urval av våra artiklar:

  1. Naeser Y, Helgadottir H, Hansson J, Ingvar C, Elander N, Flygare P, Nilsson C, Jakobsson F, del Val Munoz O, Valachis A, Papantoniou D, Nordin Danfors A, Hemming Johansson H, Sundin A, Brandberg Y och Ullenhag G. Whole-body imaging during follow-up of high-risk melanoma patients does not affect quality of life according to first year analysis of the prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma (TRIM). Cancers. 2022, 14(4):1040.
  2. Valachis A, Rosén C, Koliadi A, Digkas E, Gustavsson A, Nearchou A och Ullenhag G. Improved survival without increased toxicity with influenza vaccination in cancer patients treated with checkpoint inhibitors. Oncoimmunology. 2021, 10:1.
  3. Irenaeus S, Wenthe J, Hellström V, Tufveson G, Krause J, Sundin A, Ahlström H, Tötterman T, Loskog A och Ullenhag G. Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors. Cancer Gene Therapy. 2021, 28:1188-1197.
  4. Irenaeus S*, Nielsen D*, Ellmark P, Yachnin Y, Deronic A, Nilsson A, Norlén P, Veitonmäki N, Wennersten C och Ullenhag G. First-in-human study with intratumoral administration of a CD40 agonistic antibody, ADC-1013 in advanced solid malignancies. International journal of cancer, 2019, 145(5):1189-1199. * delat försteförfattarskap
  5. Valachis A och Ullenhag G. Discrepancy in BRAF status among patients with metastaticmalignant melanoma: a meta-analysis. European Journal of Cancer, 2017, 81:06-115. 
  6. Schiza A, Wenthe J, Mangsbo S, Eriksson E, Nilsson A, Tötterman TH, Loskog A och Ullenhag G. Adenovirus-Mediated CD40L Gene Transfer Increases Teffector/Tregulatory Cell Ratio and Upregulates Death Receptors in Melanoma Patients. Journal of Translational Medicine. 2017, 15:79.
  7. Eriksson E*, Wenthe J*, Irenaeus S, Loskog A* och Ullenhag G*. Gemcitabine Reduces MDSCs, Tregs and TGFβ-1 While Restoring the Teff/Treg Ratio in Patients with Pancreatic Cancer. Journal of Translational Medicine 2016, 14:282. * delat första- respektive sistaförfattarskap
  8. Loskog A*, Maleka A*, Mangsbo S, Svensson E, Lundberg C, Nilsson A, Krause J, Agnarsdóttir M, Sundin A, Ahlström H, Tötterman TH#, Ullenhag G#. Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients. Br J Cancer. 2016, 114(8):872-80. * delat förstaförfattarskap, # delat sistaförfattarskap
  9. Maleka A, Enblad G, Sjörs G, Lindqvist A, Ullenhag GJ. Treatment of metastatic malignant melanoma with vemurafenib during pregnancy. J Clin Oncol. 2013, (11):e192-3.
  10. Ullenhag GJ, Mukherjee A, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients. Clin Cancer Res. 2007, 13(17):5070-5.
Senast uppdaterad: 2023-01-27